|
This site provides unbiased information on weight loss, weight maintenance and wieght-related conditions
based on published biomedical research.
|
Editorial Highlights
Does your weight loss attitude need adjustment?
How to avoid weight loss scams
Diets: friends or enemies?
News Highlights
| Scheduling Of Orlistat - National Drugs And Poisons Schedule Committee, Australia | | Obesity / Weight Loss / Fitness News From Medical News Today -- 2007-02-27 | | The National Drugs and Poisons Schedule Committee (NDPSC) reconsidered the scheduling and advertising status of orlistat (contained in the medicine Xenical) at its February 2007 meeting. After reviewing a large number of submissions from consumer, industry and professional bodies, the NDPSC has decided that orlistat should be retained in Schedule 3 as a Pharmacist Only medicine. [click link for full article]...more >> |
| Long-Term Safety Data Show The LAP-BAND(R) Adjustable Gastric Banding System Results In Fewer Complications Compared To Gastric Bypass | | Obesity / Weight Loss / Fitness News From Medical News Today -- 2007-02-27 | | Researchers from Legacy Good Samaritan Obesity Institute announced today the results from a 5-year study of the safety of laparoscopic adjustable gastric banding (LAGB) compared to laparoscopic Roux-en Y gastric bypass (LRYGB), two bariatric surgical procedures performed in the United States for the treatment of morbid obesity. All patients undergoing LAGB received the LAP-BAND(R) System, which is the only FDA-approved adjustable implant device for individualized weight loss. [click link for full article]...more >> |
Research Studies Highlights
Soy compared to casein meal replacement shakes with energy-restricted diets for obese women: randomized controlled trial. [2007 Feb]
Exercise and biomarkers for cancer prevention studies. [2007 Jan]
Comparison of orlistat and sibutramine in an obesity management program: efficacy, compliance, and weight regain after noncompliance. [2006 Dec]
Effects on weight reduction and safety of short-term phentermine administration in korean obese people. [2006 Oct 31]
Obesity: new perspectives and pharmacotherapies. [2006 Sep-Oct]
Randomised controlled trial of four commercial weight loss programmes in the UK: initial findings from the BBC "diet trials". [2006 Jun 03]
Ketogenic low-carbohydrate diets have no metabolic advantage over nonketogenic low-carbohydrate diets. [2006 May]
Treatment of mild to moderate obesity with laparoscopic adjustable gastric banding or an intensive medical program: a randomized trial. [2006 May 02]
Randomized, double-blind, placebo-controlled trial of orlistat for weight loss in adolescents. [2006 Jan-Feb]
Orlistat in the treatment of overweight or obese Chinese patients with newly diagnosed Type 2 diabetes. [2005 Dec]
Effect of orlistat, micronised fenofibrate and their combination on metabolic parameters in overweight and obese patients with the metabolic syndrome: the FenOrli study. [2005 Dec]
Randomized, multi-center trial of two hypo-energetic diets in obese subjects: high-versus low-fat content. [2006 Mar]
Carbohydrate restriction alters lipoprotein metabolism by modifying VLDL, LDL, and HDL subfraction distribution and size in overweight men. [2006 Feb]
Low-fat dietary pattern and weight change over 7 years: the Women's Health Initiative Dietary Modification Trial. [2006 Jan 04]
|
